Expressive dysphasia

Published on 05/05/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1516 times

49 Expressive dysphasia

Advanced level questions

What do you know about genetics of speech?

Linkage studies of prevalent types of speech and language disorders have implicated several regions of the genome, most notably on chromosomes 3, 13, 16 and 19. The putative risk genes underlying these linkages have yet to be identified.

Mutation in FOXP2, which is located in chromosomal band 7q31 and encodes a transcription factor, has been described in a British family with autosomal dominant transmission of oral motor and speech dyspraxia. These patients have problems sequencing the precise movements of tongue, lips, jaw and palate that contribute to intelligible speech (known as verbal dyspraxia or childhood apraxia of speech). They also have difficulties with learning and production of non-speech sequences involving the orofacial musculature (orofacial dyspraxia) and have a broad profile of linguistic deficits in expressive and receptive domains—problems that affect both oral and written language. The protein product, FOXP2, downregulates the expression of CNTNAP2, a gene that encodes a neurexin protein. The general relevance of CNTNAP2 to speech dyspraxia remains to be determined. CNTNAP2 is probably associated with disorders associated with nonsense-word repetition (e.g. autism).

Genes at 7q11.23 are exquisitely sensitive to dosage alterations, which can influence human language and visuospatial capabilities.

Genetic factors have been implicated in stuttering, with linkage to markers on chromosome 12 and variations in genes governing lysosomal metabolism (N Engl J Med 2010;362:677–85).